Scaraggi, F A <br/><br/>
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.  [electronic resource] 

 -  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis  Jan 1999 
 - 33-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0957-5235 
<br/><br/><label>Standard No.: </label>10.1097/00001721-199901000-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies--blood<br/>Factor VIIa--administration & dosage<br/>Hemophilia A--blood<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Male<br/>Recombinant Proteins--administration & dosage